drugset / Trial / NCT02554981

Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®

NCT02554981

Phase 4 Completed 51 enrolled Allergan
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the efficacy of Restasis® in participants with dry eye disease who engage in electronic visual tasking.

Timeline

Start
2015-07-21
Primary completion
2016-03-24
Completion
2016-03-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 0.05 % Other

Indications